SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-040063
Filing Date
2019-11-05
Accepted
2019-11-05 07:31:47
Documents
58
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q apls-10q_20190930.htm   iXBRL 10-Q 2409554
2 EX-10.1 apls-ex101_36.htm EX-10.1 96999
3 EX-31.1 apls-ex311_11.htm EX-31.1 18447
4 EX-31.2 apls-ex312_9.htm EX-31.2 17560
5 EX-32.1 apls-ex321_6.htm EX-32.1 8576
6 EX-32.2 apls-ex322_8.htm EX-32.2 8585
7 GRAPHIC gnxlsajk22pp000004.jpg GRAPHIC 40706
8 GRAPHIC gnxlsajk22pp000001.jpg GRAPHIC 49545
9 GRAPHIC gnxlsajk22pp000002.jpg GRAPHIC 31646
10 GRAPHIC gnxlsajk22pp000003.jpg GRAPHIC 38388
  Complete submission text file 0001564590-19-040063.txt   6621007

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA apls-20190930.xsd EX-101.SCH 42662
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE apls-20190930_cal.xml EX-101.CAL 44019
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE apls-20190930_def.xml EX-101.DEF 134876
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE apls-20190930_lab.xml EX-101.LAB 336936
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE apls-20190930_pre.xml EX-101.PRE 251352
38 EXTRACTED XBRL INSTANCE DOCUMENT apls-10q_20190930_htm.xml XML 773165
Mailing Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014
Business Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014 502-241-4114
Apellis Pharmaceuticals, Inc. (Filer) CIK: 0001492422 (see all company filings)

IRS No.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38276 | Film No.: 191191761
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences